Identification of specific metabolites in culture supernatant of Mycobacterium tuberculosis using metabolomics: Exploration of potential biomarkers

Emerging Microbes and Infections

Volumn 4, Issue 1, 2015, Pages

  Lau, Susanna K P ^a,b   Lam, Ching Wan ^b   Curreem, Shirly O T ^b   Lee, Kim Chung ^b   Lau, Candy C Y ^b   Chow, Wang Ngai ^b   Ngan, Antonio H Y ^b   To, Kelvin K W ^a,b   Chan, Jasper F W ^a,b   Hung, Ivan F N ^a,b   Yam, Wing Cheong ^b   Yuen, Kwok Yung ^a,b   Woo, Patrick C Y ^a,b  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

biomarkers; diagnosis; metabolomics; Mycobacterium tuberculosis; specific

Indexed keywords

BIOLOGICAL MARKER; 1-TUBERCULOSINYLADENOSINE; DEXPANTHENOL; LIPID; PANTOTHENIC ACID;

ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; METABOLITE; METABOLOMICS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; SPECIES DIFFERENTIATION; SUPERNATANT; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANALOGS AND DERIVATIVES; ATYPICAL MYCOBACTERIUM; CLASSIFICATION; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM;

MYCOBACTERIUM; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS;

BIOMARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LIPIDS; METABOLOMICS; MYCOBACTERIUM TUBERCULOSIS; NONTUBERCULOUS MYCOBACTERIA; PANTOTHENIC ACID; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84927922346     PISSN: None     EISSN: 22221751     Source Type: Journal    
DOI: 10.1038/emi.2015.6     Document Type: Article

References (42)

1. World Health Organization. Global tuberculosis report 2014. Geneva: WHO, 2014. Available at http://www.who.int/tb/publications/global-report/en/ (accessed 2 December 2014).
2. Lai CC, Liu WL, Tan CK et al. Differences in drug resistance profiles of Mycobacterium tuberculosis isolates causing pulmonary and extrapulmonary tuberculosis in a medical centre in Taiwan, 2000-2010. Int J Antimicrob Agents 2011; 38: 125-129.
3. Jiang Y, Dou X, Zhang W et al. Genetic diversity of antigens Rv2945c and Rv0309 in Mycobacterium tuberculosis strains may reflect ongoing immune evasion. FEMS Microbiol Lett 2013; 347: 77-82.
4. Lin H, Ding H, Guo FB, Huang J. Prediction of subcellular location of mycobacterial protein using feature selection techniques. Mol Divers 2010; 14: 667-671.
5. Chan JF, Trendell-Smith NJ, Chan JC et al. Reactive and infective dermatoses associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: Sweet's syndrome and beyond. Dermatology 2013; 226: 157-166.
6. Doucette K, Fishman JA. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 2004; 38: 1428-1439.
7. Lau SK, Curreem SO, Ngan AH, Yeung CK, Yuen KY, Woo PC. First report of disseminated Mycobacterium skin infections in two liver transplant recipients and rapid diagnosis by hsp65 gene sequencing. J Clin Microbiol 2011; 49: 3733-3738.
8. Getahun H, Harrington M, O9Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resourceconstrained settings: informing urgent policy changes. Lancet 2007; 369: 2042-2049.
9. Marais BJ, Pai M. New approaches and emerging technologies in the diagnosis of childhood tuberculosis. Paediatr Respir Rev 2007; 8: 124-133.
10. Cheng VC, Yam WC, Hung IF et al. Clinical evaluation of the polymerase chain reaction for the rapid diagnosis of tuberculosis. J Clin Pathol 2004; 57: 281-285.
11. Moore DF, Curry JI. Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by Amplicor PCR. J Clin Microbiol 1995; 33: 2686-2691.
12. Olivier I, Loots DT. An overview of tuberculosis treatments and diagnostics. What role could metabolomics play? J Cell Tissue Res 2011; 11: 2655-2671.
13. Olivier I, Loots DT. A metabolomics approach to characterise and identify various Mycobacterium species. J Microbiol Methods 2012; 88: 419-426.
14. Meissner-Roloff RJ, Koekemoer G, Warren RM, Loots DT. Ametabolomics investigation of a hyper- and hypo-virulent phenotype of Beijing lineage M. tuberculosis. Metabolomics 2012; 8: 1194-1203.
15. Schoeman JC, Loots DT. Improved disease characterisation and diagnostics using metabolomics: a review. J Cell Tissue Res 2011; 11: 2673-2683.
16. Tam EW, Chen JH, Lau EC et al. Misidentification of Aspergillus nomius and Aspergillus tamarii as Aspergillus flavus : characterization by internal transcribed spacer, b-tubulin, and calmodulin gene sequencing, metabolic fingerprinting, and matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2014; 52: 1153-1160.
17. To KK, Fung AM, Teng JL et al. Characterization of a Tsukamurella pseudo-outbreak by phenotypic tests, 16S rRNA sequencing, pulsed-field gel electrophoresis, and metabolic footprinting. J Clin Microbiol 2013; 51: 334-338.
18. Woo PC, Lam CW, Tam EW et al. First discovery of two polyketide synthase genes for mitorubrinic acid and mitorubrinol yellow pigment biosynthesis and implications in virulence of Penicillium marneffei. PLoS Negl Trop Dis 2012; 6: e1871.
19. Mahadevan S, Shah SL, Marrie TJ, Slupsky CM. Analysis of metabolomic data using support vector machines. Anal Chem 2008; 80: 7562-7570.
20. Van QN, Klose JR, Lucas DA et al. The use of urine proteomic and metabonomic patterns for the diagnosis of interstitial cystitis and bacterial cystitis. Dis Markers 2003-2004; 19: 169-183.
21. Lv H, Hung CS, Chaturvedi KS, Hooton TM, Henderson JP. Development of an integrated metabolomic profiling approach for infectious diseases research. Analyst 2011; 136: 4752-4763.
22. Fend R, Kolk AH, Bessant C, Buijtels P, Klatser PR, Woodman AC. Prospects for clinical application of electronic-nose technology to early detection of Mycobacterium tuberculosis in culture and sputum. J Clin Microbiol 2006; 44: 2039-2045.
23. de Carvalho LP, Fischer SM, Marrero J, Nathan C, Ehrt S, Rhee KY. Metabolomics of Mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Chem Biol 2010; 17: 1122-1131.
24. Banday KM, Pasikanti KK, Chan EC et al. Use of urine volatile organic compounds to discriminate tuberculosis patients from healthy subjects. Anal Chem 2011; 83: 5526-5534.
25. Zhou A, Ni J, Xu Z et al. Application of 1H NMR spectroscopy-based metabolomics to sera of tuberculosis patients. J Proteome Res 2013; 12: 4642-4649.
26. Somashekar BS, Amin AG, Tripathi P et al. Metabolomic signatures in guinea pigs infected with epidemic-associated W-Beijing strains of Mycobacterium tuberculosis. J Proteome Res 2012; 11: 4873-4884.
27. Cha D, Cheng D, Liu M, Zeng Z, Hu X, Guan W. Analysis of fatty acids in sputum from patients with pulmonary tuberculosis using gas chromatography-mass spectrometry preceded by solid-phase microextraction and post-derivatization on the fiber. J Chromatogr A 2009; 1216: 1450-1457.
28. Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW. Manual of clinical microbiology. 10th ed. Washington, DC: ASM Press, 2011.
29. Tufariello JM, Jacobs WR Jr, Chan J. Individual Mycobacterium tuberculosis resuscitation-promoting factor homologues are dispensable for growth in vitro and in vivo. Infect Immun 2004; 72: 515-526.
30. Smith CA, Want EJ, O9Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 2006; 78: 779-787.
31. Tautenhahn R, Böttcher C, Neumann S. Highly sensitive feature detection for high resolution LC/MS. BMC Bioinformatics 2008; 9: 504.
32. Xia J, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS. MetaboAnalyst 2.0 - a comprehensive server for metabolomics data analyst. Nucleic Acids Res 2012; 40: W127-W133.
33. Kuhl C, Tautenhahn R, Böttcher C, Larson TR, Neumann S. CAMERA: an integrated strategy for compound spectra extraction and annotation of liquid chromatography/mass spectrometry data sets. Anal Chem 2012; 84: 283-289.
34. Layre E, Lee HJ, Young DC et al. Molecular profiling of Mycobacterium tuberculosis identifies tuberculosinyl nucleoside products of the virulence-associated enzyme Rv3378c. Proc Natl Acad Sci USA 2014; 111: 2978-2983.
35. Sartain MJ, Dick DL, Rithner CD, Crick DC, Belisle JT. Lipidomic analyses of Mycobacterium tuberculosis based on accurate mass measurements and the novel "Mtb LipidDB". J Lipid Res 2011; 52: 861-872.
36. Schlame M. Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes. J Lipid Res 2008; 49: 1607-1620.
37. Sambandamurthy VK, Wang X, Chen B et al. A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat Med 2002; 8: 1171-1174.
38. Kumar P, Chhibber M, Surolia A. How pantothenol intervenes in Coenzyme-A biosynthesis of Mycobacterium tuberculosis. Biochem Biophys Res Commun 2007; 361: 903-909.
39. Snell EE, Shive W. Growth inhibition by analogues of pantothenic acid. Pantothenyl alcohol and related compounds. J Biol Chem 1945; 158: 551-559.
40. Spry C, Chai CL, Kirk K, Saliba KJ. A class of pantothenic acid analogs inhibits Plasmodium falciparum pantothenate kinase and represses the proliferation of malaria parasites. Antimicrob Agents Chemother 2005; 49 : 4649-4657.
41. Pethe K, Swenson DL, Alonso S, Anderson J, Wang C, Russell DG. Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation. Proc Natl Acad Sci USA 2004; 101: 13642-13647.
42. Al-Mubarak R, Vander Heiden J, Broeckling CD, Balagon M, Brennan PJ, Vissa VD. Serum metabolomics reveals higher levels of polyunsaturated fatty acids in lepromatous leprosy: potential markers for susceptibility and pathogenesis. PLoS Negl Trop Dis 2011; 5: e1303.